keyword
https://read.qxmd.com/read/38652741/decorin-suppresses-tumor-lymphangiogenesis-a-mechanism-to-curtail-cancer-progression
#1
JOURNAL ARTICLE
Dipon K Mondal, Christopher Xie, Gabriel J Pascal, Simone Buraschi, Renato V Iozzo
The complex interplay between malignant cells and the cellular and molecular components of the tumor stroma is a key aspect of cancer growth and development. These tumor-host interactions are often affected by soluble bioactive molecules such as proteoglycans. Decorin, an archetypical small leucine-rich proteoglycan primarily expressed by stromal cells, affects cancer growth in its soluble form by interacting with several receptor tyrosine kinases (RTK). Overall, decorin leads to a context-dependent and protracted cessation of oncogenic RTK activity by attenuating their ability to drive a prosurvival program and to sustain a proangiogenic network...
April 30, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38652565/renal-cell-carcinoma-histologic-subtypes-exhibit-distinct-transcriptional-profiles
#2
JOURNAL ARTICLE
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle F Burgess, Benjamin A Gartrell, Sourat Darabi, Mehmet A Bilen, Arnab Basu, Daniel M Geynisman, Nancy A Dawson, Matthew R Zibelman, Tian Zhang, Shuanzeng Wei, Charles J Ryan, Elisabeth I Heath, Kelsey A Poorman, Chadi Nabhan, Rana R McKay
Molecular profiling of clear cell RCC (ccRCC) tumors of clinical trial patients has identified distinct transcriptomic signatures with predictive value, yet data in non-clear cell variants (nccRCC) are lacking. We examined the transcriptional profiles of RCC tumors representing key molecular pathways, from a multi-institutional, real-world patient cohort, including ccRCC (n = 508) and centrally-reviewed nccRCC (n = 149) samples. ccRCC had increased angiogenesis signature scores compared to the heterogeneous group of nccRCC tumors (mean z-score 0...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652547/multi-omics-characterization-of-esophageal-squamous-cell-carcinoma-identifies-molecular-subtypes-and-therapeutic-targets
#3
JOURNAL ARTICLE
Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster, Zhicai Liu, Jinwu Wang, Mee-Hyun Lee, Zigang Dong, Kangdong Liu
Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer and is characterized by an unfavorable prognosis. To elucidate the distinct molecular alterations in ESCC and investigate therapeutic targets, we performed a comprehensive analysis of transcriptomic, proteomic, and phosphoproteomic data derived from 60 paired treatment-naive ESCC and adjacent non-tumor tissue samples. Additionally, we conducted a correlation analysis to describe the regulatory relationship between transcriptomic and proteomic processes, revealing alterations in key metabolic pathways...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38651727/genomic-and-transcriptomic-landscape-of-ret-wild-type-medullary-thyroid-cancer-and-potential-use-of-mitogen-activated-protein-kinase-targeted-therapy
#4
JOURNAL ARTICLE
Sourat Darabi, Tolulope Adeyelu, Andrew Elliott, Ammar Sukari, Kurt Hodges, Farah Abdulla, Carlos E Zuazo, Trisha Wise-Draper, Thomas Wang, Michael J Demeure
BACKGROUND: About 75% of medullary thyroid cancers (MTCs) are sporadic with 45-70% being driven by a RET mutation. Selpercatinib is an approved treatment for RET-mutated (mutRET) MTC, however, treatments are needed for wild-type RET MTC (wtRET). Genomic alterations and transcriptomic signatures of wtRET MTC may reveal new therapeutic insights. METHODS: We did a retrospective analysis of MTC samples submitted for DNA/RNA sequencing and PD-L1 expression using IHC at a CLIA/CAP-certified lab...
April 23, 2024: Journal of the American College of Surgeons
https://read.qxmd.com/read/38650031/nsabp-fb-10-a-phase-ib-ii-trial-evaluating-ado-trastuzumab-emtansine-t-dm1-with-neratinib-in-women-with-metastatic-her2-positive-breast-cancer
#5
JOURNAL ARTICLE
Samuel A Jacobs, Ying Wang, Jame Abraham, Huichen Feng, Alberto J Montero, Corey Lipchik, Melanie Finnigan, Rachel C Jankowitz, Mohamad A Salkeni, Sai K Maley, Shannon L Puhalla, Fanny Piette, Katie Quinn, Kyle Chang, Rebecca J Nagy, Carmen J Allegra, Kelly Vehec, Norman Wolmark, Peter C Lucas, Ashok Srinivasan, Katherine L Pogue-Geile
BACKGROUND: We previously reported our phase Ib trial, testing the safety, tolerability, and efficacy of T-DM1 + neratinib in HER2-positive metastatic breast cancer patients. Patients with ERBB2 amplification in ctDNA had deeper and more durable responses. This study extends these observations with in-depth analysis of molecular markers and mechanisms of resistance in additional patients. METHODS: Forty-nine HER2-positive patients (determined locally) who progressed on-treatment with trastuzumab + pertuzumab were enrolled in this phase Ib/II study...
April 22, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38649964/clustering-of-hr%C3%A2-%C3%A2-her2-breast-cancer-in-an-asian-cohort-is-driven-by-immune-phenotypes
#6
JOURNAL ARTICLE
Jia-Wern Pan, Mohana Ragu, Wei-Qin Chan, Siti Norhidayu Hasan, Tania Islam, Li-Ying Teoh, Suniza Jamaris, Mee-Hoong See, Cheng-Har Yip, Pathmanathan Rajadurai, Lai-Meng Looi, Nur Aishah Mohd Taib, Oscar M Rueda, Carlos Caldas, Suet-Feung Chin, Joanna Lim, Soo-Hwang Teo
Breast cancer exhibits significant heterogeneity, manifesting in various subtypes that are critical in guiding treatment decisions. This study aimed to investigate the existence of distinct subtypes of breast cancer within the Asian population, by analysing the transcriptomic profiles of 934 breast cancer patients from a Malaysian cohort. Our findings reveal that the HR + /HER2- breast cancer samples display a distinct clustering pattern based on immune phenotypes, rather than conforming to the conventional luminal A-luminal B paradigm previously reported in breast cancers from women of European descent...
April 22, 2024: Breast Cancer Research: BCR
https://read.qxmd.com/read/38649558/first-transcriptome-analysis-of-hepatoblastoma-in-brazil-unraveling-the-pivotal-role-of-noncoding-rnas-and-metabolic-pathways
#7
JOURNAL ARTICLE
Talita Ferreira Marques Aguiar, Maria Prates Rivas, Edson Mario de Andrade Silva, Sara Ferreira Pires, Gustavo Dib Dangoni, Taiany Curdulino Macedo, Alexandre Defelicibus, Bruna Durães de Figueiredo Barros, Estela Novak, Lilian Maria Cristofani, Vicente Odone, Monica Cypriano, Silvia Regina Caminada de Toledo, Isabela Werneck da Cunha, Cecilia Maria Lima da Costa, Dirce Maria Carraro, Israel Tojal, Tiago Antônio de Oliveira Mendes, Ana Cristina Victorino Krepischi
Hepatoblastoma stands as the most prevalent liver cancer in the pediatric population. Characterized by a low mutational burden, chromosomal and epigenetic alterations are key drivers of its tumorigenesis. Transcriptome analysis is a powerful tool for unraveling the molecular intricacies of hepatoblastoma, shedding light on the effects of genetic and epigenetic changes on gene expression. In this study conducted in Brazilian patients, an in-depth whole transcriptome analysis was performed on 14 primary hepatoblastomas, compared to control liver tissues...
April 22, 2024: Biochemical Genetics
https://read.qxmd.com/read/38649537/suclg1-restricts-polrmt-succinylation-to-enhance-mitochondrial-biogenesis-and-leukemia-progression
#8
JOURNAL ARTICLE
Weiwei Yan, Chengmei Xie, Sijun Sun, Quan Zheng, Jingyi Wang, Zihao Wang, Cheuk-Him Man, Haiyan Wang, Yunfan Yang, Tianshi Wang, Leilei Shi, Shengjie Zhang, Chen Huang, Shuangnian Xu, Yi-Ping Wang
Mitochondria are cellular powerhouses that generate energy through the electron transport chain (ETC). The mitochondrial genome (mtDNA) encodes essential ETC proteins in a compartmentalized manner, however, the mechanism underlying metabolic regulation of mtDNA function remains unknown. Here, we report that expression of tricarboxylic acid cycle enzyme succinate-CoA ligase SUCLG1 strongly correlates with ETC genes across various TCGA cancer transcriptomes. Mechanistically, SUCLG1 restricts succinyl-CoA levels to suppress the succinylation of mitochondrial RNA polymerase (POLRMT)...
April 22, 2024: EMBO Journal
https://read.qxmd.com/read/38649394/malignant-features-of-minipig-melanomas-prior-to-spontaneous-regression
#9
JOURNAL ARTICLE
Héloïse Débare, Fany Blanc, Guillaume Piton, Jean-Jacques Leplat, Silvia Vincent-Naulleau, Julie Rivière, Marthe Vilotte, Sylvain Marthey, Jérôme Lecardonnel, Jean-Luc Coville, Jordi Estellé, Andrea Rau, Emmanuelle Bourneuf, Giorgia Egidy
In MeLiM minipigs, melanomas develop around birth, can metastasize, and have histopathologic characteristics similar to humans. Interestingly, MeLiM melanomas eventually regress. This favorable outcome raises the question of their malignancy, which we investigated. We clinically followed tens of tumors from onset to first signs of regression. Transcriptome analysis revealed an enrichment of all cancer hallmarks in melanomas, although no activating or suppressing somatic mutation were found in common driver genes...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38649280/tumor-agnostic-transcriptome-based-classifier-identifies-spatial-infiltration-patterns-of-cd8-t-cells-in-the-tumor-microenvironment-and-predicts-clinical-outcome-in-early-phase-and-late-phase-clinical-trials
#10
JOURNAL ARTICLE
Andreas Roller, Iakov I Davydov, Petra C Schwalie, Martha L Serrano-Serrano, Astrid Heller, Nicolas Staedler, Cláudia S Ferreira, Gabriele Dietmann, Irina Klaman, Alberto Valdeolivas, Konstanty Korski, Michael A Cannarile
BACKGROUND: The immune status of a patient's tumor microenvironment (TME) may guide therapeutic interventions with cancer immunotherapy and help identify potential resistance mechanisms. Currently, patients' immune status is mostly classified based on CD8+tumor-infiltrating lymphocytes. An unmet need exists for comparable and reliable precision immunophenotyping tools that would facilitate clinical treatment-relevant decision-making and the understanding of how to overcome resistance mechanisms...
April 22, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38648768/human-blood-serum-counteracts-egfr-her2-targeted-drug-lapatinib-impact-on-squamous-carcinoma-sk-br-3-cell-growth-and-gene-expression
#11
JOURNAL ARTICLE
Nina Shaban, Mikhail Raevskiy, Galina Zakharova, Victoria Shipunova, Sergey Deyev, Maria Suntsova, Maksim Sorokin, Anton Buzdin, Dmitri Kamashev
Lapatinib is a targeted therapeutic inhibiting HER2 and EGFR proteins. It is used for the therapy of HER2-positive breast cancer, although not all the patients respond to it. Using human blood serum samples from 14 female donors (separately taken or combined), we found that human blood serum dramatically abolishes the lapatinib-mediated inhibition of growth of the human breast squamous carcinoma SK-BR-3 cell line. This antagonism between lapatinib and human serum was associated with cancelation of the drug induced G1/S cell cycle transition arrest...
March 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38648082/kinesin-facilitates-phenotypic-targeting-of-therapeutic-resistance-in-advanced-prostate-cancer
#12
JOURNAL ARTICLE
Maddison Archer, Diane Begemann, Edgar Gonzalez-Kozlova, Prerna R Nepali, Estefania Labanca, Peter Shepherd, Navneet Dogra, Nora Navone, Natasha Kyprianou
Understanding the mechanisms underlying resistance is critical to improving therapeutic outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC). Previous work showed dynamic interconversions between epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) defines the phenotypic landscape of prostate tumors, as a potential driver of emergence of therapeutic resistance. In this study, we use in vitro and in vivo preclinical MDA PCa PDX models of resistant human prostate cancer to determine molecular mechanisms of cross-resistance between anti-androgen therapy and taxane chemotherapy, underlying the therapeutically resistant phenotype...
April 22, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38647377/drosha-regulates-mesenchymal-gene-expression-in-wilms-tumor
#13
JOURNAL ARTICLE
Patricia D B Tiburcio, Kavita Desai, Jiwoong Kim, Qinbo Zhou, Lei Guo, Xue Xiao, Li Zhou, Aysen Yuksel, Daniel R Catchpoole, James F Amatruda, Lin Xu, Kenneth S Chen
Wilms tumor, the most common pediatric kidney cancer, resembles embryonic renal progenitors. Currently, there are no ways to therapeutically target Wilms tumor driver mutations, such as in the microRNA processing gene DROSHA. Here we used a "multi-omics" approach to define the effects of DROSHA mutation in Wilms tumor. We categorized Wilms tumor mutations into four mutational subclasses with unique transcriptional effects: microRNA processing, MYCN activation, chromatin remodeling, and kidney developmental factors...
April 22, 2024: Molecular Cancer Research: MCR
https://read.qxmd.com/read/38646786/the-effect-of-baseline-o-2-conditions-on-the-response-of-prostate-cancer-cells-to-hypoxia
#14
JOURNAL ARTICLE
Ricardo Alva, Jacob E Wiebe, Jeffrey A Stuart
The transcriptional response to hypoxia is largely regulated by the hypoxia-inducible factors (HIFs), which induce the expression of genes involved in glycolysis, angiogenesis, proliferation, and migration. Virtually all cell culture-based hypoxia experiments have used near-atmospheric (18% O2 ) oxygen levels as baseline for comparison to hypoxia. However, this is hyperoxic compared to mammalian tissue microenvironments, where oxygen levels range from 2-9% O2 (physioxia). Thus, these experiments actually compare hyperoxia to hypoxia...
April 22, 2024: American Journal of Physiology. Cell Physiology
https://read.qxmd.com/read/38646657/nad-precursors-promote-the-restoration-of-spermatogenesis-in-busulfan-treated-mice-through-inhibiting-sirt2-regulated-ferroptosis
#15
JOURNAL ARTICLE
Yan-Qin Feng, Xuan Liu, Ning Zuo, Mu-Bin Yu, Wen-Meng Bian, Bao-Quan Han, Zhong-Yi Sun, Massimo De Felici, Wei Shen, Lan Li
Rationale: In recent years, nicotinamide adenine dinucleotide (NAD+ ) precursors (Npre) have been widely employed to ameliorate female reproductive problems in both humans and animal models. However, whether and how Npre plays a role in the male reproductive disorder has not been fully clarified. Methods: In the present study, a busulfan-induced non-obstructive azoospermic mouse model was used, and Npre was administered for five weeks following the drug injection, with the objective of reinstating spermatogenesis and fertility...
2024: Theranostics
https://read.qxmd.com/read/38645223/the-neuroendocrine-transition-in-prostate-cancer-is-dynamic-and-dependent-on-ascl1
#16
Rodrigo Romero, Tinyi Chu, Tania J González-Robles, Perianne Smith, Yubin Xie, Harmanpreet Kaur, Sara Yoder, Huiyong Zhao, Chenyi Mao, Wenfei Kang, Maria V Pulina, Kayla E Lawrence, Anuradha Gopalan, Samir Zaidi, Kwangmin Yoo, Jungmin Choi, Ning Fan, Olivia Gerstner, Wouter R Karthaus, Elisa DeStanchina, Kelly V Ruggles, Peter M K Westcott, Ronan Chaligné, Dana Pe'er, Charles L Sawyers
Lineage plasticity is a recognized hallmark of cancer progression that can shape therapy outcomes. The underlying cellular and molecular mechanisms mediating lineage plasticity remain poorly understood. Here, we describe a versatile in vivo platform to identify and interrogate the molecular determinants of neuroendocrine lineage transformation at different stages of prostate cancer progression. Adenocarcinomas reliably develop following orthotopic transplantation of primary mouse prostate organoids acutely engineered with human-relevant driver alterations (e...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38645065/stepwise-stiffening-softening-of-and-cell-recovery-from-reversibly-formulated-hydrogel-double-networks
#17
Irina Kopyeva, Ethan C Goldner, Jack W Hoye, Shiyu Yang, Mary C Regier, Kaitlyn R Vera, Ross C Bretherton, Cole A DeForest
UNLABELLED: Biomechanical contributions of the ECM underpin cell growth and proliferation, differentiation, signal transduction, and other fate decisions. As such, biomaterials whose mechanics can be spatiotemporally altered - particularly in a reversible manner - are extremely valuable for studying these mechanobiological phenomena. Herein, we introduce a poly(ethylene glycol) (PEG)-based hydrogel model consisting of two interpenetrating step-growth networks that are independently formed via largely orthogonal bioorthogonal chemistries and sequentially degraded with distinct bacterial transpeptidases, affording reversibly tunable stiffness ranges that span healthy and diseased soft tissues (e...
April 8, 2024: bioRxiv
https://read.qxmd.com/read/38645046/spatial-motifs-reveal-patterns-in-cellular-architecture-of-complex-tissues
#18
Zainalabedin Samadi, Amjad Askary
Spatial organization of cells is crucial to both proper physiological function of tissues and pathological conditions like cancer. Recent advances in spatial transcriptomics have enabled joint profiling of gene expression and spatial context of the cells. The outcome is an information rich map of the tissue where individual cells, or small regions, can be labeled based on their gene expression state. While spatial transcriptomics excels in its capacity to profile numerous genes within the same sample, most existing methods for analysis of spatial data only examine distribution of one or two labels at a time...
April 11, 2024: bioRxiv
https://read.qxmd.com/read/38644955/investigating-the-cell-origin-and-liver-metastasis-factors-of-colorectal-cancer-by-single-cell-transcriptome-analysis
#19
JOURNAL ARTICLE
Zhilin Sha, Qingxiang Gao, Lei Wang, Ni An, Yingjun Wu, Dong Wei, Tong Wang, Chen Liu, Yang Shen
BACKGROUND: Colorectal cancer (CRC) is one of the deadliest causes of death by cancer worldwide. Liver metastasis (LM) is the main cause of death in patients with CRC. Therefore, identification of patients with the greatest risk of liver metastasis is critical for early treatment and reduces the mortality of patients with colorectal cancer liver metastases. METHODS: Initially, we characterized cell composition through single-cell transcriptome analysis. Subsequently, we employed copy number variation (CNV) and pseudotime analysis to delineate the cellular origins of LM and identify LM-related epithelial cells (LMECs)...
2024: OncoTargets and Therapy
https://read.qxmd.com/read/38644620/dgat2-plays-a-crucial-role-to-control-esrraprox1-transcriptional-network-to-maintain-hepatic-mitochondrial-sustainability
#20
JOURNAL ARTICLE
Yoseob Lee, Yeseong Hwang, Minki Kim, Hyeonuk Jeon, Seyeon Joo, Sungsoon Fang, Jae-Woo Kim
BACKGROUND: Diacylglycerol O-acyltransferase 2 (DGAT2) synthesizes triacylglycerol (TG) from diacylglycerol; therefore, DGAT2 is considered as a therapeutic target for steatosis. However, the consequence of inhibiting DGAT2 is not fully investigated due to side effects including lethality and lipotoxicity. In this article, we observed the role of DGAT2 in hepatocarcinoma. METHODS: The role of DGAT2 is analyzed via loss-of-function assay. DGAT2 knockdown (KD) and inhibitor treatment on HepG2 cell line was analyzed...
April 22, 2024: Diabetes & Metabolism Journal
keyword
keyword
161184
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.